290 related articles for article (PubMed ID: 26357839)
1. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
Perut F; Carta F; Bonuccelli G; Grisendi G; Di Pompo G; Avnet S; Sbrana FV; Hosogi S; Dominici M; Kusuzaki K; Supuran CT; Baldini N
Expert Opin Ther Targets; 2015; 19(12):1593-605. PubMed ID: 26357839
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.
Cianchi F; Vinci MC; Supuran CT; Peruzzi B; De Giuli P; Fasolis G; Perigli G; Pastorekova S; Papucci L; Pini A; Masini E; Puccetti L
J Pharmacol Exp Ther; 2010 Sep; 334(3):710-9. PubMed ID: 20519553
[TBL] [Abstract][Full Text] [Related]
3. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis.
Yu SJ; Yoon JH; Lee JH; Myung SJ; Jang ES; Kwak MS; Cho EJ; Jang JJ; Kim YJ; Lee HS
Acta Pharmacol Sin; 2011 Jul; 32(7):912-20. PubMed ID: 21666701
[TBL] [Abstract][Full Text] [Related]
6. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
Supuran CT; Winum JY
Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
Supuran CT
Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
[TBL] [Abstract][Full Text] [Related]
12. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
Vullo D; Steffansen B; Brodin B; Supuran CT; Scozzafava A; Nielsen CU
Bioorg Med Chem; 2006 Apr; 14(7):2418-27. PubMed ID: 16321542
[TBL] [Abstract][Full Text] [Related]
14. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
15. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
[TBL] [Abstract][Full Text] [Related]
16. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.
Dubois L; Douma K; Supuran CT; Chiu RK; van Zandvoort MA; Pastoreková S; Scozzafava A; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):367-73. PubMed ID: 17502120
[TBL] [Abstract][Full Text] [Related]
17. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH.
Svastová E; Hulíková A; Rafajová M; Zat'ovicová M; Gibadulinová A; Casini A; Cecchi A; Scozzafava A; Supuran CT; Pastorek J; Pastoreková S
FEBS Lett; 2004 Nov; 577(3):439-45. PubMed ID: 15556624
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
